Based on 1 analyst offering 12 month price targets for Novo Nordisk A S
Min Forecast
$40.00+3.09%
Avg Forecast
$40.00+3.09%
Max Forecast
$40.00+3.09%
Should I buy or sell NVO stock?
Based on 1 analyst offering ratings for Novo Nordisk A S.
Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
1 analysts 100%
Although NVO's forecast from analysts indicates a "Strong Sell", our proven Zen Rating quant model rates NVO as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More
Be the first to know when Wall Street analysts revise their NVO stock forecasts and price targets.
Is Novo Nordisk (Ozempic) Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: NVO) stock is to Strong Sell NVO stock.
Out of 1 analyst, 0 (0%) are recommending NVO as a Strong Buy, 0 (0%) are recommending NVO as a Buy, 0 (0%) are recommending NVO as a Hold, 0 (0%) are recommending NVO as a Sell, and 1 (100%) are recommending NVO as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year NVO price target, the average NVO price target is $40.00, with the highest NVO stock price forecast at $40.00 and the lowest NVO stock price forecast at $40.00.
The Wall Street analyst predicted that Novo Nordisk (Ozempic)'s share price could reach $40.00 by Sep 11, 2027. The average Novo Nordisk (Ozempic) stock price prediction forecasts a potential upside of 3.09% from the current NVO share price of $38.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.